Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Once Weekly Semaglutide in Patients With Type 2 Diabetes: a Non Randomized Clinical Trial

NCT07732218 is registered in ClinicalTrials.gov with Rehman Medical Institute - RMI as lead sponsor.

NCT NCT07732218
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07732218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Once Weekly Semaglutide in Patients With Type 2 Diabetes: a Non Randomized Clinical Trial
Lead sponsor
Rehman Medical Institute - RMI
Phase
Phase 4
Overall status
Completed
Start date
July 4, 2022
Completion date
March 30, 2023
Enrollment
95 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes